fluorescein has been researched along with carbostyril in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awamura, S; Kinoshita, S; Nakamichi, N; Oshiden, K; Suzuki, H; Yokoi, N | 2 |
| Dong, T; Lei, X; Li, Q; Liu, X | 1 |
| Ichinose, A; Kakizaki, H; Takahashi, Y | 1 |
| Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M | 1 |
| Maeda, Y; Matsumiya, W; Nagai, T; Nakamura, M; Otsuka, K; Ueda, K | 1 |
| Higashide, T; Kawaguchi, C; Kawaguchi, I; Kobayashi, A; Sakurai, K; Sugiyama, K; Takeji, Y | 1 |
1 trial(s) available for fluorescein and carbostyril
| Article | Year |
|---|---|
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Coloring Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorophotometry; Humans; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Treatment Outcome; Young Adult | 2012 |
6 other study(ies) available for fluorescein and carbostyril
| Article | Year |
|---|---|
A bioorthogonal ligation enabled by click cycloaddition of o-quinolinone quinone methide and vinyl thioether.
Topics: Biotinylation; Cell Membrane Permeability; Click Chemistry; Cycloaddition Reaction; Fluorescein; HeLa Cells; Humans; Indolequinones; Molecular Imaging; Molecular Structure; Paclitaxel; Quinolones; Sulfides; Vinyl Compounds | 2013 |
A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Quinolones; Staining and Labeling; Suspensions; Tears; Time Factors; Treatment Outcome; Visual Acuity; Young Adult | 2014 |
Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
Topics: Administration, Topical; Adult; Aged; Alanine; Antioxidants; Female; Fluorescein; Fluorescent Dyes; Graves Ophthalmopathy; Humans; Keratoconjunctivitis; Limbus Corneae; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Quinolones; Retrospective Studies; Rose Bengal; Tears; Treatment Outcome | 2014 |
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Graft vs Host Disease; Humans; Middle Aged; Ophthalmic Solutions; Pemphigoid, Benign Mucous Membrane; Polyphosphates; Purinergic P2Y Receptor Agonists; Quinolones; Treatment Outcome; Uracil Nucleotides; Visual Acuity | 2015 |
Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
Topics: Aged; Alanine; Antioxidants; Cornea; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Ophthalmic Solutions; Quinolones; Retrospective Studies; Suspensions | 2015 |
Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.
Topics: Alanine; Animals; Conjunctiva; Corneal Diseases; Female; Fluorescein; Glaucoma; Microscopy, Electron, Scanning; Ophthalmic Solutions; Quinolones; Rabbits; Rose Bengal | 2017 |